Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Encephalopathy, Toxic

pyrroles has been researched along with Encephalopathy, Toxic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Li, M; Li, X; Liu, Z; Wang, Q; Wang, S; Xie, K; Yu, T1
Figueiredo-Pereira, ME; Galkin, A; Haas, A; Kiprowska, MJ; Stepanova, A; Todaro, DR; Wilson, SM1
Adriaanse, LJ; Collins, LM; Hegarty, SV; O'Keeffe, GW; Sullivan, AM; Theratile, SD1
Schiff, D; van den Bent, MJ; Wen, PY1
Kalonia, H; Kumar, A; Kumar, P2
Bodnar, L; Duchnowska, R; Miciuk, B; Szczylik, C; Waśniewski, L1
Brand, A; Gelderblom, H; Kapiteijn, E; Kroep, J1

Reviews

1 review(s) available for pyrroles and Encephalopathy, Toxic

ArticleYear
Neurological adverse effects caused by cytotoxic and targeted therapies.
    Nature reviews. Clinical oncology, 2009, Volume: 6, Issue:10

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Bevacizumab; Boronic Acids; Bortezomib; Clinical Trials as Topic; Dacarbazine; Drug Approval; Epothilones; Humans; Imatinib Mesylate; Indoles; Neoplasms; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Piperazines; Pyrazines; Pyrimidines; Pyrroles; Sunitinib; Temozolomide; Tubulin Modulators; United States; United States Food and Drug Administration

2009

Other Studies

7 other study(ies) available for pyrroles and Encephalopathy, Toxic

ArticleYear
Diallyl sulfide-induced attenuation of n-hexane-induced peripheral nerve impairment is associated with metabolic inhibition of n-hexane.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020, Volume: 137

    Topics: Allyl Compounds; Animals; Body Weight; Hair; Hexanes; Hexanones; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Pyrroles; Rats, Wistar; Sciatic Nerve; Sulfides

2020
Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease.
    Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:6

    Topics: Alzheimer Disease; Animals; Cerebral Cortex; Dose-Response Relationship, Drug; Electron Transport Complex I; Mice; Mitochondria; Neurons; Neurotoxicity Syndromes; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; tau Proteins; Ubiquitin Thiolesterase; Ubiquitination

2017
Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.
    Molecular neurobiology, 2015, Volume: 51, Issue:3

    Topics: Axons; Cell Death; Dopaminergic Neurons; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Mesencephalon; Neuroprotective Agents; Neurotoxicity Syndromes; Pyrroles

2015
Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
    Behavioural brain research, 2011, Jan-01, Volume: 216, Issue:1

    Topics: Analysis of Variance; Animals; Atorvastatin; Behavior, Animal; Body Weight; Corpus Striatum; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipid Peroxidation; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nitrites; Oxidative Stress; Pyrroles; Quinolinic Acid; Rats; Rats, Wistar; Rotarod Performance Test; Simvastatin; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2011
Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Mar-30, Volume: 35, Issue:2

    Topics: Animals; Behavior, Animal; Biochemical Phenomena; Corpus Striatum; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Huntington Disease; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Pyrroles; Quinolinic Acid; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2011
Severe neurological symptoms in a patient with advanced renal cell carcinoma treated with sunitinib.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:2

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Neoplasm Metastasis; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Pyrroles; Severity of Illness Index; Sunitinib

2013
Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:10

    Topics: Antineoplastic Agents; Female; Humans; Hypertension; Indoles; Middle Aged; Neurotoxicity Syndromes; Purpura, Thrombotic Thrombocytopenic; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2007